2-(1-Pyrrolidinyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine
C14H22BN3O2
1015242-07-5 Copyright (C) 2024 ACS
 20 22  0  0  0  0  0  0  0  0999 V2000
    1.2114    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.6672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.8854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2114    4.5526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9015    2.2763    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
    2.9962    1.0304    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9962    3.5222    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5315    1.5063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5315    3.0463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4415    2.2763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2115    3.6099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2115    0.9426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7515    3.6099    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7515    0.9426    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5215    2.2763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0615    2.2763    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9665    3.5222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9665    1.0304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4312    3.0463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4312    1.5063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  8  1  0  0  0  0
  2  8  1  0  0  0  0
  3  9  1  0  0  0  0
  4  9  1  0  0  0  0
  5  6  1  0  0  0  0
  5  7  1  0  0  0  0
  5 10  1  0  0  0  0
  6  8  1  0  0  0  0
  7  9  1  0  0  0  0
  8  9  1  0  0  0  0
 10 11  1  0  0  0  0
 10 12  2  0  0  0  0
 11 13  2  0  0  0  0
 12 14  1  0  0  0  0
 13 15  1  0  0  0  0
 14 15  2  0  0  0  0
 15 16  1  0  0  0  0
 16 17  1  0  0  0  0
 16 18  1  0  0  0  0
 17 19  1  0  0  0  0
 18 20  1  0  0  0  0
 19 20  1  0  0  0  0
M  END
